DE69918128D1 - Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen - Google Patents

Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen

Info

Publication number
DE69918128D1
DE69918128D1 DE69918128T DE69918128T DE69918128D1 DE 69918128 D1 DE69918128 D1 DE 69918128D1 DE 69918128 T DE69918128 T DE 69918128T DE 69918128 T DE69918128 T DE 69918128T DE 69918128 D1 DE69918128 D1 DE 69918128D1
Authority
DE
Germany
Prior art keywords
tfpi
dna sequence
tissue factor
muted
thrombotic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918128T
Other languages
English (en)
Other versions
DE69918128T2 (de
Inventor
Knut Kleesiek
Thomas Brinkmann
Wolfgang Prohaska
Christian Goetting
Michael Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69918128D1 publication Critical patent/DE69918128D1/de
Application granted granted Critical
Publication of DE69918128T2 publication Critical patent/DE69918128T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69918128T 1998-08-25 1999-08-18 Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen Expired - Fee Related DE69918128T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115957 1998-08-25
EP98115957 1998-08-25
PCT/EP1999/006054 WO2000011034A1 (en) 1998-08-25 1999-08-18 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders

Publications (2)

Publication Number Publication Date
DE69918128D1 true DE69918128D1 (de) 2004-07-22
DE69918128T2 DE69918128T2 (de) 2005-07-14

Family

ID=8232503

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918128T Expired - Fee Related DE69918128T2 (de) 1998-08-25 1999-08-18 Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen

Country Status (7)

Country Link
US (1) US6521410B1 (de)
EP (1) EP1105423B1 (de)
AT (1) ATE269356T1 (de)
AU (1) AU5736899A (de)
CA (1) CA2340460A1 (de)
DE (1) DE69918128T2 (de)
WO (1) WO2000011034A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436302B1 (en) * 1999-08-23 2002-08-20 Applied Materials, Inc. Post CU CMP polishing for reduced defects
CA2546171A1 (en) 2003-11-17 2005-05-26 Tm Bioscience Corporation Method of detecting mutations associated with thrombosis
WO2006066960A1 (en) * 2004-12-23 2006-06-29 Ludwig-Maximilians- Universität München Variant tfpi with increased anti-thrombotic activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104324A0 (en) * 1992-01-07 1993-05-13 Novo Nordisk As Variant of human kunitz-type protease inhibitor
US5589359A (en) * 1994-08-05 1996-12-31 Chiron Corporation Chimeric proteins

Also Published As

Publication number Publication date
WO2000011034A1 (en) 2000-03-02
EP1105423B1 (de) 2004-06-16
EP1105423A1 (de) 2001-06-13
US6521410B1 (en) 2003-02-18
AU5736899A (en) 2000-03-14
CA2340460A1 (en) 2000-03-02
DE69918128T2 (de) 2005-07-14
ATE269356T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
ATE540129T1 (de) Target zur therapie kognitiver behinderungen
UA111707C2 (uk) Застосування виділеного анти-tnf-альфа антитіла людини
DK0981343T3 (da) Probucolmonoestere til behandling af kardiovaskulær og inflammatorisk sygdom
ATE415423T1 (de) Immunisierungstherapie zur behandlung von atherosklerose
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
ATE266675T1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
ATE195149T1 (de) Protein-antagonisten der blut-koagulation und ihre verwendung
ATE307592T1 (de) Epiallopregnanolon zur behandlung von krankheiten des cns
DE69932845D1 (de) Methoden zur quantifizierung von hla-dr und cd11b
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
SE8902532D0 (sv) Bestaemning av plasmaproteiner
WO2005056585A3 (en) Sars coronavirus s proteins and uses thereof
CY1105380T1 (el) Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων
DK0845943T3 (da) Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
DE69918128D1 (de) Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
ITFI990094A0 (it) Metodo diagnostico per il riconoscimento di neoplasie umane attraverso la determinazione dell'isoforma ctn-c della tn-c,frammenti di
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE312914T1 (de) Rdgb-proteine
ATE500273T1 (de) Methoden zur analyse von antikörperdisulfidisomere
DE50214750D1 (de) Kinase inhibitoren und deren verwendung
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite
NO20006091L (no) Humant protein C-polypeptid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee